Do new therapeutic approaches (autotransplants, thalidomide, dexamethasone) improve the survival of patients with multiple myeloma followed in a rheumatology department?
S. El Mahou, B. Jamard, A. Constantin, A. Cantagrel, B. Maziéres, M. Laroche, M. Attal, C. ArnaudVolume:
25
Language:
english
Pages:
8
DOI:
10.1007/s10067-005-1151-4
Date:
March, 2006
File:
PDF, 803 KB
english, 2006